Acer Therapeutics Inc. Business Finance Contracts & Agreements

80 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to the Bridge Loan Agreement dated as of October 31, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc
Loan Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Amendment No. 1 to Unsecured Promissory Note dated as of August 30, 2023 by and between Acer Therapeutics Inc. and Christopher Schelling
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Security Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc
Security Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc
Loan Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2023
Warrant issued on June 16, 2023, by the Company to SWK Funding LLC
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Unsecured Promissory Note, dated as of June 22, 2023, between Acer Therapeutics Inc. and Christopher Schelling
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Form of Securities Purchase Agreement, dated as of March 21, 2023, between Acer Therapeutics Inc. and the Purchaser
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2023
Form of Common Stock Purchase Warrant
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Amendment Agreement dated January 30, 2023, with respect to Secured Convertible Note Purchase Agreement between Acer Therapeutics Inc., MAM Aardvark, LLC and Marathon Healthcare...
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2023
Warrant issued on January 30, 2023, by the Company to SWK Funding LLC pursuant to the Second Amendment to Credit Agreement dated January 30, 2023, among Acer Therapeutics Inc.,...
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Second Amendment to Credit Agreement dated January 30, 2023, among Acer Therapeutics Inc., the lenders party thereto and SWK Funding LLC, as the agent, sole lead arranger and sole...
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Securities Purchase Agreement, dated November 29, 2022, by and between Acer Therapeutics Inc. and the investors listed on Schedule I thereto
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Warrant issued on August 19, 2022, by the Company to SWK Funding LLC pursuant to the Amendment to Credit Agreement dated August 19, 2022, among Acer Therapeutics Inc., the lenders...
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Amendment to Credit Agreement dated August 19, 2022, among Acer Therapeutics Inc., the lenders party thereto and SWK Funding LLC, as the agent, sole lead arranger and sole...
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Form of Guarantee and Collateral Agreement to be dated the Term Loan Funding Date among Acer Therapeutics Inc. and MAM Aardvark, LLC, as agent
Loan Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Credit Agreement dated March 4, 2022, among Acer Therapeutics Inc., the lenders party thereto and MAM Aardvark, LLC, as the agent, sole lead arranger and sole bookrunner
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Form of Secured Convertible Note issuable by Acer Therapeutics Inc. to MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P. pursuant to the Secured Convertible Note...
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Secured Convertible Note Purchase Agreement dated March 4, 2022, between Acer Therapeutics Inc., MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Warrant issued on March 4, 2022, by the Company to SWK Funding LLC pursuant to the Credit Agreement dated March 4, 2022, among Acer Therapeutics Inc., the lenders party thereto...
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Guarantee and Collateral Agreement dated March 4, 2022, among Acer Therapeutics Inc. and SWK Funding LLC, as agent
Guarantee Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Credit Agreement dated March 4, 2022, among Acer Therapeutics Inc., the lenders party thereto and SWK Funding LLC, as the agent, sole lead arranger and sole bookrunner
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Waiver and Agreement, dated October 6, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG
Waiver Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2021
Security Agreement, dated January 25, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG
Security Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2021
Promissory Note, dated January 25, 2021, issued by Acer Therapeutics Inc. in favor of Relief Therapeutics Holding AG
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement, dated July 24, 2020, by and between Acer Therapeutics Inc. and the investors listed on Schedule I thereto
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2020
Registration Rights Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2020
Purchase Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2020
Description of the Companys capital stock registered pursuant to Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2020
Underwriting Agreement, dated August 1, 2018, by and among Acer Therapeutics Inc. and William Blair & Company, L.L.C. and Raymond James & Associates, Inc., as representatives of...
Underwriting Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2018
Specimen common stock certificate
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2018
Underwriting Agreement, dated December 12, 2017, by and between Acer Therapeutics Inc. and William Blair & Company, L.L.C., as Representative of the several underwriters
Underwriting Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2017
Specimen common stock certificate
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2017
SUBSCRIPTION AGREEMENT
Subscription Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2017
OPEXA THERAPEUTICS, INC. DOCS® ATM financing facility Shares of Common Stock, $0.01 par value SALES AGREEMENT March 25, 2016
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2016
AMENDMENT TO STOCK PURCHASE AGREEMENT
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2016
STOCK PURCHASE AGREEMENT
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
TX
2015
Subscription Agent Agreement, dated February 25, 2015, by and between Opexa Therapeutics, Inc. and Continental Stock Transfer & Trust Company
Subscription Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2015
Warrant Agreement, dated February 25, 2015, by and between Opexa Therapeutics, Inc. and Continental Stock Transfer & Trust Company
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2015
SUBSCRIPTION AGENT AGREEMENT [ ], 2015
Subscription Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2015